Concepedia
Statistics
Publications
7
Citations
424
H-Index
Active since
2004
Affiliations
University of Pittsburgh(Current)
Immunovaccine (Canada)
University of Pittsburgh Medical Center
Palmetto Hematology Oncology
University of Michigan
Christopher L. Oliver is an author at University of Pittsburgh specializing in medicine, bcl-xl function, and bcl-2 family proteins.
Publications per year
2004–2010
<b> <i>In vitro</i> </b> Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells
Christopher L. Oliver, Joshua A. Bauer, Keith G. Wolter et al. · Clinical Cancer Research · 2004 · 134 citations
Medicine, Oncology, Pharmacology +13
Palatal Flap Modifications Allow Pedicled Reconstruction of the Skull Base
Christopher L. Oliver, Trevor Hackman, Ricardo L. Carrau et al. · The Laryngoscope · 2008 · 105 citations
Medicine, Maxillofacial Surgery, Plastic Surgery +17
Pedicled facial buccinator (FAB) flap: A new flap for reconstruction of skull base defects
Carlos M. Rivera‐Serrano, Christopher L. Oliver, John C. Sok et al. · The Laryngoscope · 2010 · 61 citations
Medicine, Plastic Surgery, Surgery +17
(−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance
Christopher L. Oliver, Michelle B. Miranda, Sanjeev Shangary et al. · Molecular Cancer Therapeutics · 2005 · 60 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides
Sanjeev Shangary, Christopher L. Oliver, Tommy S. Tillman et al. · Molecular Cancer Therapeutics · 2004 · 34 citations
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 7